Approval · Notice of Compliance 32521 · 2024
RABAVERT: Notice of Compliance 32521
Issued January 8, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32521
- Date
- January 8, 2024
- Company
- Bavarian Nordic AsHellerup, --, Denmark
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RABAVERT | Not yet assigned | — |
Medicinal ingredients
- INACTIVATED RABIES VIRUS (FLURY LEP) 2.5 UNIT per DOSE